AMPE · Ampio Pharmaceuticals, Inc

-

Please sign in to comment on AMPE

1 Comment

Admin

4 years, 1 month ago

Ampio Pharmaceuticals, Inc is currently in a long term uptrend where the price is trading 5.0% above its 200 day moving average.

From a valuation standpoint, the stock is 100.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.0.

Ampio Pharmaceuticals, Inc's total revenue sank by nan% to $0 since the same quarter in the previous year.

Its net income has dropped by 352.7% to $-5M since the same quarter in the previous year.

Finally, its free cash flow grew by 39.2% to $-3M since the same quarter in the previous year.

Based on the above factors, Ampio Pharmaceuticals, Inc gets an overall score of 3/5.

Sector	Healthcare
Industry	Biotechnology
Exchange	PINK
CurrencyCode	USD
ISIN	US03209T1097

Market Cap	908
PE Ratio	None
Target Price	2
Beta	3.88
Dividend Yield	None

ABOUT

Ampio Pharmaceuticals, Inc

Ampio Pharmaceuticals, Inc., a biopharmaceutical company, engages in the development of therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. The company develops OA-201, a small molecule formulation for the treatment of OAK pain. Ampio Pharmaceuticals, Inc. is based in Englewood, Colorado.

AMPE · Ampio Pharmaceuticals, Inc

-

Ampio Pharmaceuticals, Inc

Earnings

Valuation

Cash Flow

Profitability

Performance

Backtest Ampio Pharmaceuticals, Inc using a moving average strategy